Catheter Precision (VTAK) EBITDA Margin Growth (1y) (2018 - 2026)

Catheter Precision (VTAK) EBITDA Margin Growth (1y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (1y) (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -430.00
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 128.00
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 301.00
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 141.00
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 102.00
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 851.00
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -313.00
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 241.00
10 Catheter Precision 635,411.82 235,411.82 390,000.00 196,343.00

Historic Data

Download Data
DateValue
Mar 31, 2026 196,343.00
Dec 31, 2025 -209,563.00
Sep 30, 2025 164,140.00
Jun 30, 2025 71,113.00
Mar 31, 2025 69,024.00
Dec 31, 2024 -1,874.00
Sep 30, 2024 -92,549.00
Jun 30, 2024 364,933.00
Mar 31, 2024 7.50 Mn
Jun 30, 2023 16.26 Mn
Mar 31, 2023 -1.71 Mn
Jun 30, 2022 -16.85 Mn
Mar 31, 2022 11.06 Mn
Sep 30, 2021 -13.68 Mn
Jun 30, 2021 40,340.00
Mar 31, 2021 -17.12 Mn
Sep 30, 2020 -1.01 Mn
Jun 30, 2020 -41,113.00
Mar 31, 2020 28,853.00
Sep 30, 2019 -68,895.00